Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease

被引:924
作者
Lange, Peter [1 ,2 ,3 ]
Celli, Bartolome [6 ]
Agusti, Alvar [7 ,9 ]
Jensen, Gorm Boje [3 ,5 ]
Divo, Miguel [6 ]
Faner, Rosa [8 ,9 ]
Guerra, Stefano [11 ]
Marott, Jacob Louis [3 ]
Martinez, Fernando D. [11 ]
Martinez-Camblor, Pablo [12 ]
Meek, Paula [13 ]
Owen, Caroline A. [6 ]
Petersen, Hans [14 ]
Pinto-Plata, Victor [6 ]
Schnohr, Peter [3 ]
Sood, Akshay [15 ]
Soriano, Joan B. [10 ]
Tesfaigzi, Yohannes [14 ]
Vestbo, Jorgen [4 ,16 ]
机构
[1] Univ Copenhagen, Inst Publ Hlth, Sect Social Med, DK-1014 Copenhagen K, Denmark
[2] Univ Copenhagen, Resp Sect, Hvidovre Hosp, DK-1014 Copenhagen K, Denmark
[3] Univ Copenhagen, Copenhagen City Heart Study, Frederiksberg Hosp, DK-1014 Copenhagen K, Denmark
[4] Univ Copenhagen, Dept Resp Med, Gentofte Hosp, DK-1014 Copenhagen K, Denmark
[5] Univ Southern Denmark, Odense, Denmark
[6] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[7] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Serv Pneumol,Thorax Inst, Barcelona, Spain
[8] Fundacio Clin Recerca Biomed, Barcelona, Spain
[9] Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain
[10] Univ Autonoma Madrid, Catedra UAM Linde, Inst Invest Hosp Univ Princesa, Madrid, Spain
[11] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA
[12] Univ Autonoma Chile, Santiago, Chile
[13] Univ Colorado, Denver, CO 80202 USA
[14] Lovelace Resp Res Inst, Albuquerque, NM USA
[15] Univ New Mexico, Albuquerque, NM 87131 USA
[16] Univ Manchester, Manchester Acad Hlth Sci Ctr, Resp & Allergy Res Grp, Manchester, Lancs, England
关键词
FORCED EXPIRATORY VOLUME; FUNCTION DECLINE; NATURAL-HISTORY; INHALED BUDESONIDE; CHILDHOOD ASTHMA; PROGRESSION; REGRESSION; MODERATE; SMOKERS; FACTS;
D O I
10.1056/NEJMoa1411532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Chronic obstructive pulmonary disease (COPD) is thought to result from an accelerated decline in forced expiratory volume in 1 second (FEV1) over time. Yet it is possible that a normal decline in FEV1 could also lead to COPD in persons whose maximally attained FEV1 is less than population norms. METHODS We stratified participants in three independent cohorts (the Framingham Offspring Cohort, the Copenhagen City Heart Study, and the Lovelace Smokers Cohort) according to lung function (FEV1 >= 80% or <80% of the predicted value) at cohort inception (mean age of patients, approximately 40 years) and the presence or absence of COPD at the last study visit. We then determined the rate of decline in FEV1 over time among the participants according to their FEV1 at cohort inception and COPD status at study end. RESULTS Among 657 persons who had an FEV1 of less than 80% of the predicted value before 40 years of age, 174 (26%) had COPD after 22 years of observation, whereas among 2207 persons who had a baseline FEV1 of at least 80% of the predicted value before 40 years of age, 158 (7%) had COPD after 22 years of observation (P<0.001). Approximately half the 332 persons with COPD at the end of the observation period had had a normal FEV1 before 40 years of age and had a rapid decline in FEV1 thereafter, with a mean (+/- SD) decline of 53 +/- 21 ml per year. The remaining half had had a low FEV1 in early adulthood and a subsequent mean decline in FEV1 of 27 +/- 18 ml per year (P<0.001), despite similar smoking exposure. CONCLUSIONS Our study suggests that low FEV1 in early adulthood is important in the genesis of COPD and that accelerated decline in FEV1 is not an obligate feature of COPD. (Funded by an unrestricted grant from GlaxoSmithKline and others.)
引用
收藏
页码:111 / 122
页数:12
相关论文
共 36 条
[1]  
Altose MD, 2000, NEW ENGL J MED, V343, P1902
[2]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[3]   Combined effect of lung function level and decline increases morbidity and mortality risks [J].
Baughman, Penelope ;
Marott, Jacob L. ;
Lange, Peter ;
Martin, Christopher J. ;
Shankar, Anoop ;
Petsonk, Edward L. ;
Hnizdo, Eva .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2012, 27 (12) :933-943
[4]   Interaction between Asthma and Lung Function Growth in Early Life [J].
Bisgaard, Hans ;
Jensen, Signe M. ;
Bonnelykke, Klaus .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (11) :1183-1189
[5]   SOME EXAMPLES OF REGRESSION TOWARDS THE MEAN .7. [J].
BLAND, JM ;
ALTMAN, DG .
BRITISH MEDICAL JOURNAL, 1994, 309 (6957) :780-780
[6]   Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[7]  
BURROWS B, 1977, AM REV RESPIR DIS, V115, P751
[8]  
BURROWS B, 1986, AM REV RESPIR DIS, V133, P974
[9]   The Progression of Chronic Obstructive Pulmonary Disease Is Heterogeneous The Experience of the BODE Cohort [J].
Casanova, Ciro ;
de Torres, Juan P. ;
Aguirre-Jaime, Armando ;
Pinto-Plata, Victor ;
Marin, Jose M. ;
Cordoba, Elizabeth ;
Baz, Rebeca ;
Cote, Claudia ;
Celli, Bartolome R. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (09) :1015-1021
[10]   Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease - Results from the TORCH study [J].
Celli, Bartolome R. ;
Thomas, Nicola E. ;
Anderson, Julie A. ;
Ferguson, Gary T. ;
Jenkins, Christine R. ;
Jones, Paul W. ;
Vestbo, Jorgen ;
Knobil, Katharine ;
Yates, Julie C. ;
Calverley, Peter M. A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (04) :332-338